Sort
8,912 grants matching “sars cov 2”
Exosome-display as a strategy to enhance the immunogenicity of SARS-CoV-2 vaccines based on adenoviral vectors
$4,732Lynda Coughlan · Icahn School Of Medicine At Mount Sinai · R21 · FY2020 · AI
Anticytokine Autoantibodies in COVID-19
$4,301Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
CSHL 2021 Eukaryotic mRNA Processing Conference
$4,000David J. Stewart · Cold Spring Harbor Laboratory · R13 · FY2021 · CA
RBD recombinant protein-based SARS vaccine for biodefense
$3,936Peter J Hotez · Baylor College Of Medicine · R01 · FY2013 · AI
RBD recombinant protein-based SARS vaccine for biodefense
$3,936Peter J Hotez · Baylor College Of Medicine · R01 · FY2014 · AI
Understanding spatial and temporal dynamics of the SARS-CoV-2 receptor, ACE2
$3,517Hans Ackerman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Repurposing of ABL kinase inhibitors for treatment of Coronavirus infections
$3,458Jeanne Sisk · University Of Maryland Baltimore · F32 · FY2016 · AI
Deciphering the RNA Biology of SARS-CoV-2
$2,898Stefan Muljo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
COVID-19 biomarker discovery
$2,762Aleksandra Nita-Lazar · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Atherogenic mechanisms of SVEP1, a Novel Human Coronary Artery Disease Locus
$2,500Jared Scott Elenbaas · Washington University · F30 · FY2021 · HL
Incidence, Outcomes, and Predictors of Sepsis in Hospitalized Patients with COVID-19
$2,500Claire Shappell · Brigham And Women'S Hospital · F32 · FY2022 · GM
Epidemiology, immunology, and evolution of SARS-CoV-2 and other coronaviruses before and during the COVID-19 pandemic
$1,477Leah Katzelnick · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
COVID-19 biomarker discovery
$1,155Aleksandra Nita-Lazar · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Identifying existing, FDA-approved drugs with clinically protective effects against coronavirus disease 2019 using a big data approach
$1Harpal Singh Sandhu · University Of Louisville · R21 · FY2021 · LM
The Effect of Social Isolation on Lexical Retrieval in Elderly Adults
$1Amy Victoria Vogel-Eyny · Cuny Graduate Sch And Univ Ctr · R21 · FY2022 · AG
Administrative Core
$1Clayton Yates · Tuskegee University · U54 · FY2022 · MD
Mentoring in Advanced mHealth Technologies and Machine Learning for HIV/Drug Abuse Research
$1Edward W Boyer · Brigham And Women'S Hospital · K24 · FY2021 · DA
RFA-GH-21-006, SICA Study: Seroepidemiological Insight into COVID-19 transmission in Africa
$1Rhoel David Ramos Dinglasan · University Of Florida · U01 · FY2023 · GH
Temple University Gastroparesis Clinical Center
$1Henry P. Parkman · Temple Univ Of The Commonwealth · U01 · FY2022 · DK
Assessing the long-term impacts of the COVID-19 pandemic on disparities in cancer screening and follow-up
$1John F Dickerson · Kaiser Foundation Research Institute · R01 · FY2024 · CA
Initiation of immune responses to SARS COV2 in the oral cavity and upper airway
$1Sarah C Glover · University Of Mississippi Med Ctr · R01 · FY2023 · DE
Innate immune factors governing restriction of human coronaviruses
$1Caitlin Stoddard · Fred Hutchinson Cancer Center · R00 · FY2025 · AI
Nosocomial pneumonia impairs the cerebrovasculature
$1Amy R Nelson · University Of South Alabama · R01 · FY2025 · NS
Training Program in Infectious Diseases in the Immunocompromised Host
$1Michael J Boeckh · Fred Hutchinson Cancer Research Center · T32 · FY2021 · AI
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
$1Pia S Pannaraj · Children'S Hospital Of Los Angeles · R01 · FY2023 · AI